Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Viruses could deliver HIV, malaria, rabies and cancer vaccines as pills

06.04.2005


Rabies, HIV, cancer and malaria could all be prevented with pills in the future, if a new technique using specially modified viruses to deliver vaccines is adopted, according to scientists speaking today (Tuesday, 05 April 2005) at the Society for General Microbiology’s 156th Meeting at Heriot-Watt University, Edinburgh.



"We can take a special type of virus which only infects bacteria, called a bacteriophage, and replace some of its DNA with vaccine DNA, and then use the phage to deliver vaccines in a highly efficient way," says Dr John March of the Moredun Research Institute, Penicuik, near Edinburgh.

A vaccine packaged in this way is cheap, simple to make, stable, and environmentally safe according to the researchers. Because the phage vaccine can be safely stored at room temperature as a dry powder, it should be possible to turn it into a pill form and deliver it as an oral vaccine. Since the phages can mass produce themselves the system would be very cheap, and easy to store and administer, making it ideal for use in the developing world to protect against diseases such as HIV/AIDS and malaria.


"We have already tested oral delivery of these vaccines, and the data suggest that they work," says Dr March. "We have successful test results from mice, rabbits and sheep - animals in which conventional DNA vaccines do not work - so we are confident that the technique will work for people. Bacteriophages have been used as medicines in eastern Europe since the 1930s to fight bacterial infections, so we have a long history of their safe use in humans, and of large scale manufacturing."

The phage vaccines have several advantages over traditional ’naked’ DNA vaccines - they can contain much larger sections of DNA, triggering a more effective immune response. Because the phage vaccine is protected within a virus shell it can be targeted at specific cells in the body, and the shell stops it breaking down and becoming ineffective.

The new vaccines can also be used for diseases where the vaccine material is difficult or expensive to produce using conventional approaches, such as for cancers. The doses needed are much smaller than conventional DNA vaccines, where high doses and multiple injection regimes are often needed. The large cloning capacity of phages means that several vaccines could be delivered simultaneously.

The main applications will be in producing cheap general vaccines for the developing world, and in specialist applications in the developed world in situations where conventional vaccines do not work. In developing countries a pill form of vaccine would do away with the need for scarce and expensive cold storage systems, and also will have no need for a constant supply of clean needles.

"Wildlife use is also ideal since phages are cheap and stable so we can use them in baits or with oral delivery," says Dr March. "This would be ideal for a rabies vaccine, where wildlife programmes will play a major role in disease eradication. The antibody response against the phage is a useful side effect as it gives us a simple marker to tell between vaccinated and naturally infected animals."

"The special phages we are using cannot replicate outside the laboratory, so they are environmentally safe and friendly," explains Dr John March. "The fact that we can make them with the bare minimum of laboratory equipment and expertise only adds to the potential of this exciting new technology."

Faye Jones | alfa
Further information:
http://www.sgm.ac.uk

More articles from Life Sciences:

nachricht Immune Defense Without Collateral Damage
23.01.2017 | Universität Basel

nachricht The interactome of infected neural cells reveals new therapeutic targets for Zika
23.01.2017 | D'Or Institute for Research and Education

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Tracking movement of immune cells identifies key first steps in inflammatory arthritis

23.01.2017 | Health and Medicine

Electrocatalysis can advance green transition

23.01.2017 | Physics and Astronomy

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>